Our Services
Medical Information
Helpful Resources
Published on: 2/25/2026
High triglycerides raise the risk of heart disease, stroke, and, when very high, pancreatitis; fenofibrate is FDA approved and research backed to primarily lower triglycerides by about 30 to 50 percent, making it vital when levels are markedly elevated.
There are several factors to consider. See below for medically approved next steps, including confirming fasting labs, checking for secondary causes, starting targeted lifestyle changes, discussing fenofibrate or combination therapy with your clinician, and arranging regular monitoring.
High triglycerides are more than just a lab number. They are a clear signal that your body is struggling to process fats properly. When triglycerides remain elevated over time, they increase the risk of heart disease, stroke, and in severe cases, pancreatitis—a painful and potentially dangerous inflammation of the pancreas.
If your doctor has mentioned fenofibrate, it's not random. Fenofibrate is a medically approved and widely studied medication specifically designed to lower triglyceride levels and improve overall lipid balance.
Let's break down what high triglycerides mean, why fenofibrate is often recommended, and what your next steps should be.
Triglycerides are a type of fat (lipid) found in your blood. After you eat, your body converts unused calories into triglycerides and stores them in fat cells for later energy use.
Some triglycerides are normal and necessary. Problems start when levels become elevated:
Very high levels significantly increase the risk of acute pancreatitis, which can require hospitalization.
Elevated triglycerides often occur alongside:
This combination increases the risk of:
Importantly, high triglycerides usually cause no symptoms until complications develop. That's why routine blood testing matters.
If you're concerned about abnormal cholesterol or triglyceride levels and want to understand your personal risk better, you can use a free AI-powered symptom checker for Dyslipidemia to evaluate your symptoms and receive personalized health insights in minutes.
Fenofibrate is a prescription medication approved by the FDA to treat:
It belongs to a class of drugs called fibrates.
Unlike statins, which mainly lower LDL cholesterol, fenofibrate primarily targets triglycerides.
Fenofibrate activates a receptor in the body called PPAR-alpha (peroxisome proliferator-activated receptor alpha). This leads to:
In simple terms: fenofibrate helps your body process and clear fats more efficiently.
Fenofibrate becomes especially important in certain medical situations.
At this level, the risk of acute pancreatitis rises significantly.
Pancreatitis symptoms include:
Pancreatitis can be life-threatening. In these cases, lowering triglycerides quickly is not optional—it's urgent. Fenofibrate is often one of the first-line treatments.
People with type 2 diabetes frequently have:
Clinical research has shown that fenofibrate can reduce certain cardiovascular complications in high-risk diabetic patients, particularly when triglycerides are elevated and HDL is low.
When patients have:
Fenofibrate may be used alone or in combination with a statin (under medical supervision).
Credible clinical studies and professional guidelines support the use of fenofibrate for:
Major cardiology and endocrinology organizations recommend fibrates like fenofibrate when triglycerides remain high despite lifestyle changes, especially when levels exceed 500 mg/dL.
For most people, fenofibrate is well tolerated. However, like any medication, it has potential side effects.
This is why doctors monitor:
Never start or stop fenofibrate without medical supervision.
Medication is not a replacement for healthy habits. It works best with lifestyle changes.
For some people, lifestyle changes alone are enough. For others—especially with genetic or metabolic conditions—fenofibrate becomes medically necessary.
It's important not to ignore persistent elevation.
Potential consequences include:
This is not meant to alarm you—but unmanaged lipid disorders can quietly cause serious harm over time.
The good news? They are highly treatable.
You should speak to a doctor if:
If you experience:
Seek immediate medical care. These may indicate serious complications.
If your triglycerides are elevated, here's a practical path forward:
Repeat testing ensures accuracy.
Your doctor may assess for:
Often started immediately.
If triglycerides remain high or are dangerously elevated, fenofibrate may be prescribed.
Regular blood work every 3–6 months initially.
High triglycerides are common—but they are not harmless.
When levels are significantly elevated, fenofibrate is a medically approved, research-backed treatment that can dramatically lower triglycerides and reduce serious risks like pancreatitis and cardiovascular disease.
It is not a cosmetic medication. It addresses a real metabolic imbalance.
If you haven't had recent blood work or are experiencing symptoms that concern you, taking a free symptom assessment for Dyslipidemia can help you understand whether your symptoms warrant a conversation with your doctor.
Most importantly, speak to a doctor about your triglyceride levels and whether fenofibrate is appropriate for you. Lipid disorders are highly manageable when addressed early—and delaying care only increases long-term risk.
Taking action now is not overreacting. It's preventive medicine at its best.
(References)
* Kastelein JJP, Reiner Ž, Leiter LA. Fenofibrate for the treatment of hypertriglyceridemia: An expert panel opinion. Clin Lipidol. 2018;13(4):307-318. doi:10.2217/clp-2018-0026.
* Sacks FM, Carey VJ, Goel S, et al. The effect of fenofibrate on cardiovascular disease. J Clin Lipidol. 2018 Sep-Oct;12(5):1135-1144. doi: 10.1016/j.jacl.2018.06.002. Epub 2018 Jun 15.
* Wilson DP, Nambi V, Smith SC Jr, et al. Management of Hypertriglyceridemia: A Clinical Update From the National Lipid Association. J Clin Lipidol. 2020 Nov-Dec;14(6):687-702. doi: 10.1016/j.jacl.2020.09.006. Epub 2020 Sep 17.
* Sahebkar A, Serban C, Mikhailidis DP, et al. Fibrates: A Current Review of Pharmacology and Clinical Efficacy. Lipids Health Dis. 2019 Jun 10;18(1):128. doi: 10.1186/s12944-019-1065-4.
* Lu J, Huang P, Han J, et al. Fenofibrate in patients with hypertriglyceridemia: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2019 May 28;18(1):118. doi: 10.1186/s12944-019-1064-5.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.